19 results
Thumbnail

D3.260 - Shiitake-Induced Flagellate Dermatitis: Case Series from Kazakhstan

Thumbnail

D3.261 - Orphan Diseases In Allergology - Melkersson-Rosenthal Syndrome

Thumbnail

D3.264 - Delayed Type Hypersensitivity Injection Site Reaction Induced By Liraglutide

Thumbnail

D3.265 - Gleish syndrome: A case report

Thumbnail

D3.266 - Component-Resolved Delayed Hypersensitivity to Piperacillin/Tazobactam and Clavulanic Acid Despite Structural Divergence

Thumbnail

D3.267 - Statistics of Contributing Factors to Atopic Dermatitis in Children

Thumbnail

D3.256 - A Child with Mastocytosis presenting with generalized severe Pruritus: A Diagnostic Pitfall

Thumbnail

D3.258 - Not just a rash: a delayed diagnosis of allopurinol-induced dress syndrome

Thumbnail

D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region

Thumbnail

D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report

Thumbnail

D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor

Thumbnail

D3.153 - Add-on Dupilumab therapy significantly reduces severe asthma exacerbations and emergency visits in patients with severe persistent asthma requiring oral corticosteroids for maintenance therapy: our experience in Réunion Island

Thumbnail

D3.154 - Trends in Bronchial Asthma Incidence in Crimea: Analysis from 2017-2024 with Age-Specific Insights

Thumbnail

D3.155 - Th2–Th17 immune shift following dupilumab therapy

Thumbnail

D3.156 - Pulmonary embolism in a young asthma patient

Thumbnail

D3.159 - Early Bronchodilator Response in Asthma: When Is Testing Really Necessary?

Thumbnail

D3.160 - Study of the allergic sensitization profile in asthmatic patients consulting at ignace deen university hospital, conakry

Thumbnail

D3.161 - Efficacy and Safety of Ciclesonide in Achieving Asthma Control: Results of an Observational Multicenter Study in Real-World Clinical Practice

Thumbnail

D3.164 - Early and Sustained Effect of Zumilokibart (APG777) in Atopic Dermatitis and Asthma: 16-Week Results from the Phase 2 APEX Study in Moderate-to-Severe AD and a Phase 1b Study in Mild-to-Moderate Asthma